Omission of axillary staging in elderly patients with early stage breast cancer impacts regional control but not survival: A systematic review and meta-analysis.

Abstract:

INTRODUCTION:Management of early breast cancer in the elderly population is challenging due to different breast cancer biology and limited tolerance to aggressive treatments. The aim of this study is to evaluate whether the omission of axillary staging impacts breast cancer outcomes in elderly patients. PATIENTS AND METHODS:A systematic review and meta-analysis was carried out following the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. The electronic databases were searched in August 2014 using the following inclusion criteria: RESULTS: Two RCTs met the eligibility criteria and were included. A meta-analysis of the included RCTs of 692 patients found that axillary staging reduced the risk of axillary recurrence compared to no axillary staging (RR 0.24, 95% CI: 0.06 to 0.95, I2=0%, p=0.04). There were no differences observed in in-breast recurrence or distant recurrence (RR 1.20, 95% CI: 0.55 to 2.64, I2=62%, p=0.65, RR 1.17, 95% CI: 0.75 to 1.82, I2=0%, p=0.48, respectively). There were no differences observed in overall or breast-cancer specific mortality (RR 0.99, 95% CI: 0.79 to 1.24, I2=0%, p=0.92, RR 1.07, 95% CI: 0.72 to 1.57, I2=0%, p=0.75, respectively). DISCUSSION:Omission of axillary staging in elderly patients with clinically negative axillae results in increased regional recurrence but does not appear to impact survival.

journal_name

J Geriatr Oncol

authors

Liang S,Hallet J,Simpson JS,Tricco AC,Scheer AS

doi

10.1016/j.jgo.2016.12.003

subject

Has Abstract

pub_date

2017-03-01 00:00:00

pages

140-147

issue

2

eissn

1879-4068

issn

1879-4076

pii

S1879-4068(16)30168-0

journal_volume

8

pub_type

杂志文章,meta分析,评审
  • Moving beyond symptom management towards cancer rehabilitation for older adults: Answering the 5W's.

    abstract::Older adults with cancer are quickly becoming the largest group of cancer survivors. Chronological age is a poor predictor of cancer treatment outcomes and of the need for rehabilitation services. While newer symptom management systems and assessments are slowly becoming used in the clinic to improve communication bet...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2017.11.009

    authors: Pergolotti M,Lyons KD,Williams GR

    更新日期:2018-11-01 00:00:00

  • Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort.

    abstract:OBJECTIVE:Clinical trials investigating breast cancer treatment often exclude or misrepresent older adults. This study compares treatment patterns and survival of older women diagnosed with breast cancer between a Dutch and a British observational cohort. MATERIALS AND METHODS:Women aged 70 years and older diagnosed w...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2018.05.004

    authors: Schuil H,Derks M,Liefers GJ,Portielje J,van de Velde C,Syed B,Green A,Ellis I,Cheung KL,Bastiaannet E

    更新日期:2018-11-01 00:00:00

  • Patient-reported psychosocial needs and psychological distress predict survival in geriatric oncology patients.

    abstract:OBJECTIVES:Little is known about how psychosocial factors and distress affect older patients with cancer and their survival. The study goals were to: 1) observe the prevalence of anxiety (ANX) and depression (DEP) symptoms at diagnosis in patients aged ≥65 years, 2) observe the association between social isolation (iso...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.10.001

    authors: Leung B,Shokoohi A,Bates A,Ho C

    更新日期:2020-11-04 00:00:00

  • Global geriatric oncology: Achievements and challenges.

    abstract::The aging of the population is a global challenge. The number of older adults is rapidly growing, leading to an increase in the prevalence of noncommunicable diseases associated with aging, such as cancer. Worldwide, older adults account for approximately half of all cancer cases, and this proportion is projected to i...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2017.06.001

    authors: Soto-Perez-de-Celis E,de Glas NA,Hsu T,Kanesvaran R,Steer C,Navarrete-Reyes AP,Battisti NML,Chavarri-Guerra Y,O'Donovan A,Avila-Funes JA,Hurria A

    更新日期:2017-09-01 00:00:00

  • Patient-reported and objectively measured physical function in older breast cancer survivors and cancer-free controls.

    abstract:OBJECTIVES:Older breast cancer survivors (BCS) consistently report more functional limitations than women without cancer, but whether or not these differences remain when using objective measures of physical functioning and the correlates of these measures is unknown. METHODS:Cross-sectional study comparing older (≥60...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2018.10.006

    authors: Winters-Stone KM,Medysky ME,Savin MA

    更新日期:2019-03-01 00:00:00

  • Aromatase inhibitors: The unexpected breast cancer treatment.

    abstract:OBJECTIVE:Suboptimal adherence with endocrine treatment for breast cancer is influenced by a number of factors but remains poorly understood. We sought to describe the prior knowledge about and expectations of breast cancer treatments among older women retrospecting on their diagnosis and treatment. METHODS:Thematic a...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.07.024

    authors: Pieters HC,Green E,Sleven M,Stanton AL

    更新日期:2020-04-01 00:00:00

  • Using heat maps to assess the multidimensional association of comorbidities with survival in older cancer patients treated with chemotherapy.

    abstract:OBJECTIVE:To date, most comorbidity studies have analyzed either a subgroup of frequent diseases, or used summary instruments such as the Charlson score or the Cumulative Illness Rating Scale-Geriatric (CIRS-G). Yet, comorbidity is a multidimensional construct and impacts function, treatment tolerance, and survival. We...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2017.07.005

    authors: Lee JJ,Kim J,Sehovic M,Chen L,Extermann M

    更新日期:2017-09-01 00:00:00

  • Controversial issues in the management of older adults with early breast cancer.

    abstract::It is well recognized that the incidence of breast cancer increases significantly with age. Despite this, older people remain under-represented in many clinical trials and their management relies on extrapolation of data from younger patients. Providing an aggressive intervention can be challenging, particularly in le...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2017.05.004

    authors: Mislang AR,Cheung KL,Hamaker ME,Kunkler I,Markopoulos C,Orecchia R,Brain E,Biganzoli L

    更新日期:2017-11-01 00:00:00

  • Sociodemographic, socioeconomic, and clinical determinants of survival in patients with cancer: A systematic review of the literature focused on the elderly.

    abstract::Studies on cancer survival have revealed disparities not only between the elderly and their younger counterparts, but also among the elderly themselves. The aim of this work was to identify sociodemographic, socioeconomic, clinical, and care-related determinants of survival or mortality in older patients with cancer b...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2017.07.007

    authors: Galvin A,Delva F,Helmer C,Rainfray M,Bellera C,Rondeau V,Soubeyran P,Coureau G,Mathoulin-Pélissier S

    更新日期:2018-01-01 00:00:00

  • How (and why) to ask the older cancer patient about sexual health and sexual minority status.

    abstract::Sexual health and sexual minority status are often undiscussed during oncology visits. Yet, these topics should be addressed in older cancer patients in order to help mitigate the sexual side effects of cancer treatment and to acknowledge - and, at times, help provide - the social support older patients need during th...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2019.08.003

    authors: Cathcart-Rake E,O'Connor JM,Jacobson A,McGuire L,Jatoi A

    更新日期:2020-05-01 00:00:00

  • Outcomes based on age in patients with metastatic renal cell carcinoma treated with first line targeted therapy or checkpoint immunotherapy: Older patients more prone to toxicity.

    abstract:OBJECTIVES:Older patients with metastatic renal cell carcinoma (mRCC) were underrepresented in pivotal trials. MATERIALS AND METHODS:Consecutive patients with mRCC treated at Aarhus University Hospital with first line tyrosine kinase inhibitors (TKI), mTOR inhibitors, or checkpoint immunotherapy (CPI) were retrospecti...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.12.008

    authors: Hermansen CK,Donskov F

    更新日期:2020-12-31 00:00:00

  • Systematic review of falls in older adults with cancer.

    abstract:OBJECTIVES:Older adults frequently experience falls, at great cost to themselves and society. Older adults with cancer may be at greater risk for falls and have unique risk factors. MATERIALS AND METHODS:We undertook a systematic review of the available medical literature to examine the current evidence regarding fact...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2014.10.003

    authors: Wildes TM,Dua P,Fowler SA,Miller JP,Carpenter CR,Avidan MS,Stark S

    更新日期:2015-01-01 00:00:00

  • Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia.

    abstract:OBJECTIVES:To investigate changes in inflammatory biomarkers during induction therapy for older adults with acute myeloid leukemia (AML) and their associations with geriatric assessment (GA) measures and outcomes. METHODS:This was a single institution ancillary study to a prospective observational study (N = 20 consec...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.03.014

    authors: Loh KP,Tooze JA,Nicklas BJ,Kritchevsky SB,Williamson JD,Ellis LR,Powell BL,Pardee TS,Goyal NG,Klepin HD

    更新日期:2020-04-01 00:00:00

  • Impact of age on treatment trends and clinical outcome in patients with metastatic renal cell carcinoma.

    abstract:OBJECTIVES:Clinical outcomes in older adults with metastatic renal cell carcinoma (mRCC) are poorly understood, particularly in the era of targeted therapies. We characterize survival and relevant treatment-related variables in a modern series. MATERIALS AND METHODS:From an institutional database including 562 patient...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2012.11.001

    authors: Pal SK,Hsu J,Hsu S,Hu J,Bergerot P,Carmichael C,Saikia J,Liu X,Lau C,Twardowski P,Figlin RA,Yuh BF

    更新日期:2013-04-01 00:00:00

  • 21-gene recurrence score testing utilization among older women from different races: A population-based study.

    abstract:OBJECTIVES:The influence of older age at diagnosis in combination with race/ethnicity on utilization and results of the 21-gene recurrence score (RS) assay for breast cancer (BC) patients is not fully understood. Our objectives were to evaluate the utilization of RS among older women with BC, the likelihood of a high-r...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.06.004

    authors: Gulbahce HE,White S,Herget KA,Stoddard G,Camp NJ,Buys SS,Sweeney C

    更新日期:2020-07-07 00:00:00

  • An evaluation of elderly patients (≥70 years old) enrolled in Phase I clinical trials at University of Texas Health Science Center at San Antonio-Cancer Therapy Research Center from 2009 to 2011.

    abstract:OBJECTIVE:Elderly patients with cancer are under-represented in clinical trials, and there is especially scant data on their participation in early-phase trials. In an effort to provide more data, we reviewed our Phase I experience. METHODS:We conducted a retrospective analysis of 461 patients enrolled in Phase I clin...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2013.08.005

    authors: Rowe J,Patel S,Mazo-Canola M,Parra A,Goros M,Michalek J,Kelly K,Weitman S,Karnad A

    更新日期:2014-01-01 00:00:00

  • Clinical judgment versus geriatric assessment for frailty in older patients with cancer.

    abstract:BACKGROUND:Geriatric assessment (GA) is an appropriate method for identifying frailty in older patients with cancer, but a shorter instrument may be easier to use in clinical practice. Clinical judgment is always available and requires no investments in time or resources. The purpose of this study was to assess correla...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.05.011

    authors: van Walree IC,Scheepers ERM,van den Bos F,van Huis-Tanja LH,Emmelot-Vonk MH,Hamaker ME

    更新日期:2020-09-01 00:00:00

  • Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care.

    abstract:BACKGROUND:An oncogeriatric approach may affect management of elderly patients with breast cancer. However, little is known about oncogeriatric care in the metastatic setting. Therefore, we performed an international comparison of management of elderly patients with primary metastatic disease who were treated in two di...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.jgo.2014.02.005

    authors: van de Water W,Bastiaannet E,Egan KM,de Craen AJ,Westendorp RG,Balducci L,van de Velde CJ,Liefers GJ,Extermann M

    更新日期:2014-07-01 00:00:00

  • HER2 status in elderly women with breast cancer.

    abstract:OBJECTIVES:HER2 (human epidermal growth factor receptor 2) is an important biomarker in breast cancer, but its prevalence in elderly women is not well established. Previous studies reported HER2 status based on either immunohistochemistry (IHC) or fluorescent in situ hybridization (FISH) interchangeably. However, the t...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2013.05.007

    authors: Laird-Fick HS,Gardiner JC,Tokala H,Patel P,Wei S,Dimitrov NV

    更新日期:2013-10-01 00:00:00

  • Attributes of caregivers' quality of life: A perspective comparison between spousal and non-spousal caregivers of older patients with cancer.

    abstract:PURPOSE:With the aging population, our current understanding of patients with cancer and their family caregivers needs to be expanded to older patients with cancer and their caregivers. By differentiating spousal caregivers and non-spousal caregivers, we aimed to investigate the universalities and particularities of ca...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.05.020

    authors: Jeong A,Shin D,Park JH,Park K

    更新日期:2020-01-01 00:00:00

  • Older survivors of cancer in the COVID-19 pandemic: Reflections and recommendations for future care.

    abstract:PURPOSE:Although the year after cancer treatment is challenging for all cancer survivors, older adults (≥60 years) face additional challenges due to age-related decline and high rates of comorbidity. There is a paucity of research on how health service interruptions from the COVID-19 pandemic have impacted the experien...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.11.009

    authors: Haase KR,Kain D,Merchant S,Booth C,Koven R,Brundage M,Galica J

    更新日期:2020-12-03 00:00:00

  • Optimal management of localized rectal cancer in older patients.

    abstract::In advising the optimal management for older patients, health care professionals try to balance the risks from frailty, vulnerability, and comorbidity against the patient's ultimate prognosis, potential functional outcomes and quality of life (QOL). At the same time it is important to involve the patient and incorpora...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2018.08.001

    authors: Bujko K,Glynne-Jones R,Papamichael D,Rutten HJT

    更新日期:2018-11-01 00:00:00

  • Envisioning Arti's 'Cadillac study' to assess aging trajectories in cancer survivors.

    abstract::The "Cadillac Study" was the term Arti Hurria, MD often used to articulate her vision of the optimal study to investigate the effects of cancer and its treatments on aging trajectories. In her opinion, this study needed to be designed for near-term clinical translation and have the ability to discern subpopulations of...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.06.009

    authors: Guida JL,Green PA,Gallicchio L

    更新日期:2020-03-01 00:00:00

  • Detection of frailty in elderly cancer patients: Improvement of the G8 screening test.

    abstract:OBJECTIVE:The G8 is a screening test to identify frail elderly patients with cancer. Objectives were to design and evaluate the performance of alternative tests taking into account other predictive domains for frailty. METHODS:We conducted a literature review to identify predictive factors of frailty. Using a Delphi c...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2016.01.004

    authors: Petit-Monéger A,Rainfray M,Soubeyran P,Bellera CA,Mathoulin-Pélissier S

    更新日期:2016-03-01 00:00:00

  • Delirium incidence, risk factors, and treatments in older adults receiving chemotherapy: A systematic review and meta-analysis.

    abstract:INTRODUCTION:Older adults with cancer are at increased risk of delirium due to age, comorbidities, medications, cognitive impairment, and possibly cancer treatments. However, there is scant information on the risks of delirium with chemotherapy and approaches to prevent or treat it. We performed a systematic review and...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.08.011

    authors: Jung P,Puts M,Frankel N,Syed AT,Alam Z,Yeung L,Malik U,Rosario C,Ayala AP,Hudson J,Alibhai SMH

    更新日期:2020-09-14 00:00:00

  • Activities, function, and health-related quality of life (HRQOL) of older adults with cancer.

    abstract:OBJECTIVE:This study aims to (1) describe the activities, function, and health-related quality of life (HRQOL) of a large sample of older adults (age ≥65) with cancer, (2) identify the associations with demographics, cancer type, comorbid conditions, and ability to participate in activities and functional status. MATE...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2017.02.009

    authors: Pergolotti M,Deal AM,Williams GR,Bryant AL,Bensen JT,Muss HB,Reeve BB

    更新日期:2017-07-01 00:00:00

  • Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLD.

    abstract:BACKGROUND:Regorafenib significantly increases overall survival (OS) in patients with metastatic colorectal cancer previously treated but gives toxicities. OBJECTIVES:to assess the efficacy and safety of regorafenib at it's approved dose in the older population. PATIENTS AND METHODS:This multicenter single-arm phase ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.04.001

    authors: Aparicio T,Darut-Jouve A,Khemissa Akouz F,Montérymard C,Artru P,Cany L,Romano O,Valenza B,Le Foll C,Delbaldo C,Falandry C,Norguet Monnereau E,Ben Abdelghani M,Smith D,Rinaldi Y,Père Verge D,Baize N,Maillard E,Dohan A

    更新日期:2020-11-01 00:00:00

  • Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS).

    abstract:OBJECTIVES:This study aims to investigate the use of chemotherapy with or without bevacizumab in older patients with metastatic colorectal cancer (mCRC) in current daily practice and to identify predictive parameters for treatment-related outcomes. PATIENTS AND METHODS:This is a Belgian multi-centre, observational coh...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.jgo.2017.10.002

    authors: Decoster L,Kenis C,Naessens B,Houbier G,De Man M,Lambrecht G,Monsaert E,Moons V,Vergauwe P,Prenen H,Van Cutsem E,Wildiers H

    更新日期:2018-03-01 00:00:00

  • Management and supportive treatment of frail patients with metastatic pancreatic cancer.

    abstract::Data regarding management of frail patients with pancreatic ductal adenocarcinoma practice is currently very scarce. Randomized clinical trials usually exclude these subgroup of patients and the majority of the publications only consider chronological age and ECOG performance status for their classification. Therefore...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2018.06.005

    authors: Macarulla T,Carrato A,Díaz R,García A,Laquente B,Sastre J,Álvarez R,Muñoz A,Hidalgo M

    更新日期:2019-05-01 00:00:00

  • Corrigendum to "Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicenter prospective study" [J. Geriatr. Oncol. 6 (2015) 401-410].

    abstract::The authors regret: A calculation error was corrected in Table 3. As mentioned under the table, the percentage of patients under ‘Baseline’ was calculated from the total no. of patients with geriatric recommendations data (n = 932 pts). This was mistakenly calculated from the number of patients with available GA data ...

    journal_title:Journal of geriatric oncology

    pub_type: 已发布勘误

    doi:10.1016/j.jgo.2016.01.005

    authors: Baitar A,Kenis C,Moor R,Decoster L,Luce S,Bron D,Van Rijswijk R,Rasschaert M,Langenaeken C,Jerusalem G,Lobelle JP,Flamaing J,Milisen K,Wildiers H

    更新日期:2016-03-01 00:00:00